BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30464619)

  • 1. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer.
    Wei J; Huang R; Guo S; Zhang X; Xi S; Wang Q; Chang H; Wang X; Xiao W; Zeng Z; Gao Y
    Cancer Manag Res; 2018; 10():5219-5225. PubMed ID: 30464619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal tumor fragmentation as a response pattern following chemoradiation.
    Mills MN; Naz A; Sanchez J; Dessureault S; Imanirad I; Lauwers G; Moore M; Hoffe S; Frakes J; Felder S
    J Gastrointest Oncol; 2022 Dec; 13(6):2951-2962. PubMed ID: 36636056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Detection of RUNX3 and EZH2 in Evaluating Efficacy of Neoadjuvant Therapy and Prognostic Value of Middle and Low Locally Advanced Rectal Cancer.
    Wang L; Wu X; Xu W; Gao L; Wang X; Li T
    Front Oncol; 2022; 12():713335. PubMed ID: 35280723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer.
    Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
    Medicine (Baltimore); 2016 Jan; 95(3):e2272. PubMed ID: 26817863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0.
    Cui Y; Liu X; Li S; Wang H; Xiang Y; Zhang Y; Song M; Geng J; Liu Z; Teng H; Zhu X; Cai Y; Li Y; Wang W
    Clin Transl Oncol; 2024 Apr; 26(4):1012-1021. PubMed ID: 38051436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
    Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.
    Tang YL; Li DD; Duan JY; Wang X
    Int J Colorectal Dis; 2024 Jun; 39(1):93. PubMed ID: 38896374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
    Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
    World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of tumor regression grade with outcomes in patients with locally advanced rectal cancer treated with preoperative two-week course of radiotherapy.
    Li YH; Li JL; Zhu XG; He JY; Lin LM; Lin XY; Tang LR; Cai Y
    Oncotarget; 2017 Nov; 8(59):100165-100175. PubMed ID: 29245968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
    Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: influencing factors and prognostic significance.
    Lu X; Qi R; Xu Y; Wang X; Cai Y; Wang C
    Int J Clin Exp Pathol; 2023; 16(6):124-132. PubMed ID: 37425225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
    Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
    Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.
    Trakarnsanga A; Gönen M; Shia J; Nash GM; Temple LK; Guillem JG; Paty PB; Goodman KA; Wu A; Gollub M; Segal N; Saltz L; Garcia-Aguilar J; Weiser MR
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25249540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients.
    Min BS; Kim NK; Pyo JY; Kim H; Seong J; Keum KC; Sohn SK; Cho CH
    J Korean Soc Coloproctol; 2011 Feb; 27(1):31-40. PubMed ID: 21431095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into tumor regression grade as a parameter for locally advanced rectal cancer and 5-year overall survival rate.
    Laohawiriyakamol S; Chaochankit W; Wanichsuwan W; Kanjanapradit K; Laohawiriyakamol T
    Ann Coloproctol; 2023 Feb; 39(1):59-70. PubMed ID: 36891632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
    Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
    Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.